- Home
- BDX vs EW Comparison
BDX vs EW Comparison
Compare BDX & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDX
- EW
- Stock Information
- Founded
- BDX 1897
- EW 1958
- Country
- BDX United States
- EW United States
- Employees
- BDX N/A
- EW N/A
- Industry
- BDX Medical/Dental Instruments
- EW Industrial Specialties
- Sector
- BDX Health Care
- EW Health Care
- Exchange
- BDX Nasdaq
- EW Nasdaq
- Market Cap
- BDX 49.0B
- EW 45.5B
- IPO Year
- BDX 1962
- EW 2000
- Fundamental
- Price
- BDX $188.36
- EW $74.54
- Analyst Decision
- BDX Buy
- EW Buy
- Analyst Count
- BDX 9
- EW 19
- Target Price
- BDX $222.75
- EW $85.74
- AVG Volume (30 Days)
- BDX 1.6M
- EW 4.0M
- Earning Date
- BDX 11-06-2025
- EW 10-23-2025
- Dividend Yield
- BDX 2.21%
- EW N/A
- EPS Growth
- BDX 12.91
- EW 188.09
- EPS
- BDX 5.47
- EW 7.02
- Revenue
- BDX $21,386,000,000.00
- EW $5,685,100,000.00
- Revenue This Year
- BDX $9.41
- EW $13.25
- Revenue Next Year
- BDX $4.70
- EW $9.76
- P/E Ratio
- BDX $34.45
- EW $10.62
- Revenue Growth
- BDX 7.86
- EW 9.14
- 52 Week Low
- BDX $163.33
- EW $64.01
- 52 Week High
- BDX $251.99
- EW $83.00
- Technical
- Relative Strength Index (RSI)
- BDX 48.30
- EW 26.88
- Support Level
- BDX $185.16
- EW $80.08
- Resistance Level
- BDX $190.02
- EW $76.43
- Average True Range (ATR)
- BDX 3.39
- EW 1.65
- MACD
- BDX -0.89
- EW -0.76
- Stochastic Oscillator
- BDX 45.13
- EW 15.49
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.